← Back to Patent Explorer
US5104641A Expired / Lapsed US ⏱️ 0.0 years remaining

Nitroxide NMR contrast enhancing agents and their use in NMR imaging

Assignee: NITROSCI MEDICAL PRODUCTS LLC
•
Filing: 1990-02-26
•
Granted: 1992-04-14
•
Expires: 2010-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Nitroxides useful as NMR contrast enhancing agents for organs are of the formula ##STR1## wherein in the above formulae, R 1 , R 2 , R 3 and R 4 are, g., CH 3 ; R is --B--COO--M + or --B--N(alkyl) 3 Hal - , wherein B is a divalent bond or alkylene of 1-8 carbon atoms, M is an ammonium or metal ion and Hal is a halogen atom; are also useful as NMR contrast enhancing agents on joints.

Inventors

  • 👤 Gerald M. Rosen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 02:35
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/54; G01R33/56; G01R33/5601; A; A61; A61K; A61K49/00; A61K49/06; A61K49/20; C; C07; C07D; C07D207/00; C07D207/46; C07D211/00; C07D211/92; C07D211/94; Y; Y10; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 235 words
A method of enhancing the image obtained by NMR scanning of an organ associated with the cardiovascular system of a human being which comprises injecting into the blood of the human being, prior to the NMR scan on the organ, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both nontoxic and effective to reduce the relaxation time of the blood during the scanning period sufficiently to enhance the NMR image produced by the scan of a charged, stable organic nitroxide of the formula: ##STR8## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 2
Independent Claim 235 words
A method of enhancing the image obtained by NMR scanning of an organ associated with the cardiovascular system of a human being which comprises injecting into the blood of the human being, prior to the NMR scan on the organ, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both nontoxic and effective to reduce the relaxation time of the blood during the scanning period sufficiently to enhance the NMR image produced by the scan of a charged, stable organic nitroxide of the formula: ##STR8## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 3
Dependent Claim 18 words
A method according to claim 1, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 4
Dependent Claim 41 words
A method according to claim 2, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 wherein B is alkylene of 1-4 carbon atoms and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 5
Dependent Claim 40 words
A method according to claim 2, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 6
Dependent Claim 12 words
A method according to claim 1, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 7
Dependent Claim 16 words
A method according to claim 1, wherein R is --alk--COO - M + as defined therein.
Claim 8
Dependent Claim 23 words
A method according to claim 6, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 9
Dependent Claim 33 words
A method according to claim 6, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , and M + is Na + or K + .
Claim 10
Dependent Claim 15 words
A method according to claim 1, wherein the nitroxide is the sodium salt of 2,2,5,5l-tetramethyl-3l-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.
Claim 11
Independent Claim 221 words
A method of enhancing the image obtained by NMR scanning of the joint of an animal which comprises injecting into the joint of the animal, prior to the NMR scan on the joint, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both non-toxic and effective to enhance the NMR image produced by the scan of a neurologically acceptable and nontoxic charged, stable organic nitroxide of the formula: ##STR9## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 12
Independent Claim 221 words
A method of enhancing the image obtained by NMR scanning of the joint of an animal which comprises injecting into the joint of the animal, prior to the NMR scan on the joint, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both non-toxic and effective to enhance the NMR image produced by the scan of a neurologically acceptable and nontoxic charged, stable organic nitroxide of the formula: ##STR9## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 13
Dependent Claim 18 words
A method according to claim 10, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 14
Dependent Claim 43 words
A method according to claim 1, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is alkylene of 1 to 4 carbon atoms and Alk is alkyl of 1 to 4 carbon atoms.
Claim 15
Dependent Claim 40 words
A method according to claim 1, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 16
Dependent Claim 12 words
A method according to claim 10, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 17
Dependent Claim 16 words
A method according to claim 10, wherein R is --alk--COO - M + as defined therein.
Claim 18
Dependent Claim 23 words
A method according to claim 15, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 19
Dependent Claim 33 words
A method according to claim 15, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , and M + is Na + or K + .
Claim 20
Dependent Claim 15 words
A method according to claim 10, wherein the nitroxide is the sodium salt of 2,2,5,5-tetramethyl-3-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.
Claim 21
Dependent Claim 191 words
A pharmaceutical composition adapted for injection into the blood intravenously or into the joint of a human being comprising per unit dosage amount a non-toxic NMR image enhancing amount in a sterile solution vehicle of a charged, stable organic nitroxide of the formula ##STR10## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 22
Dependent Claim 191 words
A pharmaceutical composition adapted for injection into the blood intravenously or into the joint of a human being comprising per unit dosage amount a non-toxic NMR image enhancing amount in a sterile solution vehicle of a charged, stable organic nitroxide of the formula ##STR10## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 23
Dependent Claim 18 words
A composition according to claim 19, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 24
Dependent Claim 43 words
A composition according to claim 20, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 wherein B is alkylene of 1 to 4 carbon atoms and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 25
Dependent Claim 40 words
A composition according to claim 19, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond, and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 26
Dependent Claim 12 words
A composition according to claim 19, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 27
Dependent Claim 16 words
A composition according to claim 19, wherein R is --alk--COO - M + as defined therein.
Claim 28
Dependent Claim 23 words
A composition according to claim 24, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 29
Dependent Claim 41 words
A composition according to claim 24, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is alkylene of 2-4 carbon atoms and M + is Na + or K + .
Claim 30
Dependent Claim 15 words
A composition according to claim 19, wherein the nitroxide is the sodium salt of 2,2,5,5l-tetramethyl-3-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.

References Cited (Backward Citations)

US3502692A Cited
US4656026A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-04-14 1995-10-14 1996-04-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-04-14 1999-10-14 2000-04-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-04-14 2003-10-14 2004-04-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag